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Introduction:  Pharyngocutaneous  ﬁstula  is a  well-known  complication  of head  and  neck  cancer  surgery.
The purpose  of  this  study  was  to  determine  the  value  of negative-pressure  wound  therapy  (NPWT)  for  the
treatment  of these  ﬁstulas.  NPWT  is  used  in many  ﬁelds  of  medicine,  but  its  use  in  otorhinolaryngology
has  been  rarely  reported.  NPWT  is a cost-effective  means  to  accelerate  wound  healing.
Patients  and  methods:  A single-centre  retrospective  study  was  conducted  on  7  patients  with  pharyngo-
cutaneous  ﬁstula  following  surgery  for  squamous  cell  carcinoma  between  January  2011  and  April  2013.
These  ﬁstulas  were  treated  by negative-pressure  wound  therapy  (NPWT).
Results:  This  series  comprised  seven  male  patients  with  a mean  age  of  65  years  and  9 months.  The mean
duration  of  treatment  was  23  days  (range:  11  to  42  days).  Two  patients  had a history  of radiotherapy  for
pharyngolaryngeal  cancer.  Negative-pressure  wound  therapy  achieved  cure  of  the ﬁstula  in  all  patients
with  satisfactory  acceptability.  Mean  follow-up  was  10 months  (range:  6 months  to  2 years).
Conclusion:  Negative-pressure  wound  therapy  represents  a valuable  treatment  option  in certain  settings
for the  management  of pharyngocutaneous  ﬁstula  following  head  and  neck  cancer  surgery.
©  2014  Published  by Elsevier  Masson  SAS.. Introduction
Poor wound healing is a common problem in head and neck can-
er surgery, generally observed in malnourished patients treated
y radiotherapy and/or chemotherapy. The pharyngolaryngeal
ucosa and neck tissues present altered trophicity and are sub-
itted to the aggressive action of saliva or even gastro-oesophageal
eﬂux.
Pharyngocutaneous ﬁstula increases morbidity and mortality
nd prolongs the length of hospital stay. It is frequently located
djacent to the tracheostoma, making tracheostoma care more dif-
cult and sometimes requiring redo surgery. Negative-pressure
ound therapy (NPWT) is an alternative treatment option for the
anagement of pharyngocutaneous ﬁstula.
The use of NPWT was ﬁrst reported by Fleischmann et al. in
993 [1] and then in 1995 [2]. Many publications have subsequently
escribed the use of NPWT for the treatment of sternal, sacral,
pper and lower limb, perineal and abdominal wounds [3]. How-
ver, few publications have reported the use of NPWT in head and
eck surgery. In 2006, Schuster et al. [4] reported the ﬁrst successful
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879-7296/© 2014 Published by Elsevier Masson SAS.use of this therapy on a complex lesion of the face. In the same
year, Andrews et al. [5] reported the treatment of complex head
and neck injuries and, in 2008, they then demonstrated the value of
NPWT for the treatment of pharyngocutaneous ﬁstula in 2 patients
with ﬁstula closure in 6 days and 11 days, respectively [6]. In 2005,
Rosenthal et al. [7] also used NPWT to treat complications of head
and neck cancer surgery in 23 patients, including 4 patients with
pharyngocutaneous ﬁstula. The mean duration of treatment was
6.25 days for these 4 patients.
This article describes the use of NPWT to speciﬁcally treat
pharyngocutaneous ﬁstulas occurring after surgery for pharyngo-
laryngeal or oral cancer and the results obtained.
2. Patients and methods
A single-centre retrospective study was conducted from Jan-
uary 2011 to April 2013 on patients of the department of
otorhinolaryngology and head and neck surgery of our institution
with pharyngocutaneous ﬁstula following partial laryngectomy,
total laryngectomy transmandibular oropharyngectomy, treated
by negative-pressure wound therapy.
Epidemiological data were collected from the patients’ medi-
cal charts. Pharyngocutaneous ﬁstula was deﬁned as salivary leak
in the neck. In doubtful cases, the ﬁstula was demonstrated by
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Table 1
Negative-pressure wound therapy devices and manufacturers.
Name of the medical device Manufacturers or distributors
ATMOS SO 41 ATMOS Médical, France
Engenex Boehringer, Phoenix USA
Exsudex Synergy Healthcare plc, Swindon UK
VAC therapy KCI, San Antonio USA
RENASYS Smith & Nephew, London UK
Venturi Talley, Romsey UK
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AC: vacuum-assisted closure.
ethylene blue test. No patient was concomitantly treated by
yperbaric oxygen therapy.
The course of wound healing was evaluated at each change of
ressing, i.e. every 48 to 72 hours, until complete healing. The dress-
ng was systematically changed by the surgeon or the intern at
he patient’s bedside. The dressing was maintained until complete
ealing of the ﬁstula (no discharge visible when changing the dress-
ng and/or negative methylene blue test). Subsequent management
onsisted of healing by secondary intention.
Several companies currently propose NPWT devices in France:
ENASYS, VAC therapy (vacuum-assisted closure) and WOUND
SSIST (Table 1). In this study, we used the Smith and Nephew
ENASYS system in continuous mode with negative pressures ran-
ing from −100 to −125 mmHg. This device can be used according
o various modes with intermittent or continuous pressure, and
ressures ranging from −25 to −200 mmHg. Pharyngocutaneous
stulas require a relatively high pressure to achieve an occlusive
eal [7].
Seven patients (7 males with a mean age of 65 years 9 months)
ith postoperative pharyngocutaneous ﬁstula between January
011 and April 2013 were included in this study. The following
perations had been performed: one total laryngectomy, one total
ircular pharyngolaryngectomy, two partial laryngectomies, one
ransmandibular oropharyngectomy and two salvage total laryn-
ectomies. Only these last two patients had a history of external
eam radiotherapy for a previous head and neck cancer. Only one
atient presented insulin-dependent diabetes.
. Results
Seven patients were included in this study. The dressing was
ell-tolerated by all patients, both in the long term and at the
ime of dressing changes. The mean duration of NPWT was  23 days
range: 11 days to 42 days). All NPWT dressings achieved complete
ealing of the ﬁstula.
The mean follow-up was 10 months (range: 6 months to 2
ears). Early recurrence of a low-output ﬁstula was observed at
ne week and resolved spontaneously after ﬁve days without the
se of NPWT.
Patient 1, 77 years old, was treated by total laryngectomy and
ilateral neck dissection for stage T3N2aM0 squamous cell carci-
oma of the larynx. He developed pneumonia with deterioration of
is general condition on postoperative day 3, requiring admission
o the intensive care unit for 5 days.
On day 15, a salivary leak was observed in the neck, adjacent to
he tracheostoma. Surgery was not proposed in view of the patient’s
oor general state and it was decided to treat the ﬁstula by NPWT.
even days after starting NPWT, it was difﬁcult to obtain an air-
ight dressing due to the proximity of the tracheostoma and skin
olds. Tulle gras dressing was then aspirated into the leaking zones
o ensure an airtight dressing (Fig. 1). The ﬁstula had closed after
8 days of NPWT. Healing by secondary intention with alginate
acking was continued for 7 days until complete skin healing wasFig. 1. Tulle gras placed in skin folds.
obtained. Two-year follow-up conﬁrmed the absence of recurrence
of the ﬁstula.
Patient 2, 72 years old, a smoker and heavy drinker, was
operated by transmandibular oropharyngectomy with ipsilateral
functional neck dissection for stage T3N2bM0 squamous cell carci-
noma of the right oropharynx. Early wound dehiscence and salivary
leak were observed on postoperative day 6. The patient was reop-
erated for debridement and closure by a right pectoralis major
myocutaneous ﬂap.
On day 7, the patient developed cervical cellulitis that was
treated medically, leading to the formation of another pharyngo-
cutaneous ﬁstula.
NPWT was  installed on postoperative day 12 for 18 days. On
day 26, air leaks related to the conformation of the wound and the
proximity of the tracheostoma were also observed. This problem
was resolved by the use of tulle gras dressing.
The ﬁstula was  closed on day 30 and NPWT was stopped. Com-
plete healing was  obtained on day 40. Clinical follow-up at 10
months did not reveal any signs of recurrence of the ﬁstula.
Patient 3, 57 years old, an insulin-dependent diabetic with
a history of squamous cell carcinoma of the larynx treated by
radiotherapy (65 Gy) ten years previously, presented with a stage
T3N0M0 carcinoma of the larynx. Salvage total laryngectomy was
proposed. The initial course was satisfactory, with no healing prob-
lems despite difﬁculties controlling his diabetes.
On day 30, the patient suddenly developed an infectious com-
plication with a neck abscess responsible for wound dehiscence
and right pharyngocutaneous ﬁstula directly adjacent to the tra-
cheostoma. Attempted direct closure by mucosal suture under
general anaesthesia was  unsuccessful. A left pectoralis major
myocutaneous ﬂap was  performed on day 39 and it was  decided
to install NPWT intraoperatively in view of the poor condition of
the tissues. NPWT was  designed to direct the ﬁstula away from the
tracheostoma in order to simplify subsequent dressing changes.
Despite these precautions, low left cervical wound dehiscence was
observed 3 days later. A second NPWT dressing was inserted on
day 42 after the ﬁrst operation. Closure of the two ﬁstulas was
obtained after 21 and 24 days of NPWT, respectively. Dressings
were continued by alginate packing for 7 days after stopping NPWT,
until complete healing. One-year follow-up demonstrated com-
plete healing and absence of recurrence.
Patient 4, 65 years old, had a history of stage T2N0M0 squamous
cell carcinoma of the larynx treated by external beam radiotherapy
at a dose of 65 Gy three years previously (refusal of surgery). He
presented with a stage T4N2M0 local recurrence requiring salvage
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otal laryngectomy with closure by a right pectoralis major muscle
ap.
On postoperative day 10, a pharyngocutaneous ﬁstula was
bserved in a context of local and systemic sepsis. Surgical revi-
ion for drainage, lavage and mucosal suture allowed closure of the
stula. Flap viability remained satisfactory. In view of the poor local
onditions, despite the absence of ﬁstula, it was decided to close the
ound over a NPWT device. Foam was placed in the neck wound.
he initial postoperative course was favourable, but another ﬁstula
ppeared at the tracheostoma oriﬁce. As NPWT dressings could not
e performed at this site, it was decided to redirect the ﬁstula away
rom the tracheostoma in order to install the NPWT in a zone allow-
ng the dressings to be performed and to close the distal part of the
stula by the combined action of drainage and tissue apposition
nduced by negative pressure. A counter-incision above and away
rom the tracheostoma over the ﬁstula tract were performed under
ocal anaesthetic. This option allowed effective closure of the ﬁstula.
PWT was stopped after a total of 42 days and alginate dressings
ere continued for 6 days until complete healing. No recurrence of
he ﬁstula was observed with a follow-up of 9 months.
Patient 5, 72 years old, with chronic obstructive pulmonary dis-
ase, presented a stage T2N2cM0 squamous cell carcinoma of the
eft vallecula spreading to the epiglottis and to the junctional region
f the oropharynx. Treatment consisted of supraglottic laryngec-
omy with modiﬁed bilateral radical dissection, after performing
emporary tracheotomy. On postoperative day 7, a neck abscess
as observed, associated with wound dehiscence and pharyngo-
utaneous ﬁstula. NPWT was placed immediately, allowing rapid
losure of the ﬁstula, and was removed on day 11. Follow-up at 6
onths conﬁrmed the absence of recurrence of the ﬁstula.
Patient 6, 54 years old, a chronic smoker and heavy drinker,
resented with stage T3N0M0 squamous cell carcinoma of the
ight vallecula spreading to the right pyriform sinus as far as the
ase of the tongue. Horizontal partial laryngectomy with right
eck dissection was performed, followed by infection and abscess
n postoperative day 1 and then right pharyngocutaneous ﬁs-
ula, treated by NPWT for 25 days to achieve closure of the
stula. Conventional mesh dressings were continued for 7 days. No
haryngocutaneous ﬁstula was observed at 6-month follow-up.
Patient 7, 62 years old, presented with a double T4N2cM0
umour of the pharyngolaryngeal wall associated with a tumour
f the posterior pharyngeal wall. Total circular pharyngola-
yngectomy was performed with bilateral neck dissection and
econstruction by radial forearm free ﬂap. On day 1, the patient
resented an extensive neck haematoma requiring reoperation to
nsure haemostasis. On day 8, a neck abscess was  observed, fol-
owed by an abundant pharyngocutaneous ﬁstula. The patient was
eoperated to ensure debridement and wound closure. The ﬂap
resented satisfactory viability with a patent vascular pedicle.
On postoperative day 10 after the initial surgery, two  pharyn-
ocutaneous ﬁstulas were observed on each side, away from the
racheostoma. NPWT was installed on day 13 and was stopped after
2 days on the left side and 26 days on the right side.
Wound care was continued with alginate dressings. Another
bscess was observed on the right side, associated with a small
stula. This minimally productive ﬁstula was treated by healing by
econdary intention using a mixture of honey and rusks ingested
wice a day, combined with intravenous amoxicillin. The ﬁstula
as closed after 7 days. Follow-up at 6 months did not reveal any
ecurrence of the pharyngocutaneous ﬁstula.. Discussion
Impaired wound healing and the formation of pharyngocu-
aneous ﬁstula in the context of head and neck cancer can bey, Head and Neck diseases 131 (2014) 351–355 353
explained by a number of interrelated factors. Risk factors for post-
operative complications identiﬁed in the literature are mainly a
history of neoadjuvant radiotherapy, low serum albumin, diabetes
and long operating times [8]. There is a higher risk of postopera-
tive ﬁstula in patients undergoing salvage laryngectomy, especially
when it is performed within 12 months after high-dose radiation
therapy (greater than 65 Gy) or following concomitant chemora-
diotherapy [9].
Bohannon et al. tried to identify risk factors for recurrent ﬁs-
tula following salvage laryngectomy. They showed that, apart from
radiotherapy, hypothyroidism was  a statistically signiﬁcant risk
factor for recurrence of pharyngocutaneous ﬁstula [10]. Chronic
corticosteroid therapy and gastro-oesophageal reﬂux have also
been proposed as possible risk factors for ﬁstula, but have not been
shown to be statistically signiﬁcant [10].
Various treatment modalities for pharyngocutaneous ﬁstula
have been reported in the literature:
• hyperbaric oxygen therapy, which is not very effective on ﬁstulas
[11];
• ingestion of a combination of honey and rusks to ﬁll the ﬁstula
[12];
• alginate dressings with intense draining properties [13];
• surgical closure by a pedicled latissimus dorsi ﬂap or a free
jejunum ﬂap [14];
• ﬁrst-line use of Tachosil® on the total laryngectomy T-shaped
suture is currently under evaluation [15].
NPWT appears to be a valuable alternative in these settings of
impaired healing. In non-oncological head and neck surgery, NPWT
is already used to treat deep abscesses of the neck that are difﬁcult
to manage by conventional dressings [16,17].
Negative-pressure wound therapy consists of an application of a
pressure difference between a wound sealed by an airtight dressing
and the external environment, which transforms this open wound
into a controlled closed wound allowing management of secretions.
Negative pressure is applied by means of polyurethane foam
cut to the dimensions of the wound and placed under an occlusive
dressing, in which a hole is made. A soft port is then connected to the
hole in the dressing and is then connected to the negative pressure
generator by tubing. The soft port is secured hermetically onto the
occlusive dressing, with the opening of the soft port positioned over
the hole in the dressing. The other end of the tubing is connected
to a canister attached to the pump to collect secretions. This bat-
tery or main powered portable pump is used to adjust the negative
pressure applied to the wound from −25 to −200 mmHg, in contin-
uous or intermittent mode. Dressing instructions are summarized
in Fig. 2.
The main expected beneﬁts of NPWT are a reduction of the size
and complexity of the wound and consequently decreased com-
plexity of surgical reconstruction, when required. NPWT promotes
the formation of granulation tissue and healing [18,19]. Finally,
NPWT allows management of secretions in a perfectly airtight
closed system with less frequent dressing changes and preven-
tion of infection as a result of the probable reduction of bacterial
contamination of the wound [20].
Conventional dressings performed for pharyngocutaneous ﬁs-
tula, comprising irrigation and packing, are often repeated (twice
daily), requiring one or two nurses. NPWT decreases the dressing
frequency (every 48 to 72 h) and consequently the nurse’s workload
as well as the patient’s discomfort related to dressing changes and
stagnation of partially absorbed secretions. In the present series,
dressings were performed by a doctor due to the technical difﬁcul-
ties and the need to adapt treatment to the course of the ﬁstula.
Outpatient use of this device, as in other surgical specialties, does
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Fig. 2. Dressing 
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debrided, when necessary, NPWT is able to promote more rapid for-Fig. 3. Use of a colostomy wafer to ensure an airtight seal.
ot appear to be very realistic in the speciﬁc setting of postoperative
stula.
The use of NPWT in neck dressings, particularly in tra-
heotomized patients, raises speciﬁc problems. Although NPWT is
 very ﬂexible device that can be adapted to a wide range of dress-
ngs, it is sometimes difﬁcult to maintain an airtight seal due to the
osition of the ﬁstula. An airtight dressing may  be impossible when
he ﬁstula is situated too close to the tracheostoma, but an airtight
ressing is essential to ensure the efﬁcacy of NPWT. The neck also
omprises zones of hair and skin folds, responsible for maceration
nd detachment of the dressings. Finally, secretions derived from
he tracheostoma further complicate the situation. Speciﬁc strate-
ies must therefore be deﬁned to manage NPWT in the presence of
eaks and poor adhesion in a moist environment, in an anatomically
nfavourable zone.
What techniques are available to avoid leaks due to the prox-
mity of the tracheostoma? We  have successfully used tulle gras,
hich is aspirated by NPWT into the leaking zones (Fig. 1). We also
ystematically use hydrocolloid dressings in the interface between
he polyurethane dressing and the skin in order to protect the skin
n the context of these repeated dressings associated with a risk of
kin avulsion.
Finally, the most appropriate device to maintain an airtight seal
ppears to be a colostomy wafer, whose very principle is to main-
ain a watertight seal in a moist environment. It is also associated
ith excellent skin tolerance (Fig. 3).
The NPWT device is contraindicated in the following situations:uncontrolled wound infection [18];
presence of necrotic tissue requiring debridement;technique.
• absence of interface between the gastrointestinal tract and the
negative-pressure system;
• non-revascularized arterial disease;
• residual tumour after resection;
• in the presence of more than 50% of ﬁbrin or in the presence of a
pressure ulcer.
Theoretical precautions should also be observed in some sit-
uations, but they remain relative and must be adapted to each
patient: enterocutaneous ﬁstula and cavities, clotting disorders
(risk of bleeding) and the presence of exposed vessels or organs.
Few adverse effects have been reported with NPWT, but they
must be kept in mind. The patient may  experience varying degrees
of pain, especially during dressing changes. A simple method to
relieve this pain is to inject 0.2% lidocaine directly into the foam
before removal [21]. If the patient experiences pain when negative
pressure is applied to the foam, the pressure should be decreased
until the pain resolves. Lidocaine injection was  not performed in
any of the cases of the present series. The system also constitutes a
permanent constraint for patients and is constantly noisy.
No precise guidelines have been established concerning the
pressure to be applied to the wound. Timmers et al. [22] measured
cutaneous blood ﬂow by Doppler in a healthy arm after application
of negative pressure via foam, ranging from −25 to −300 mmHg.
They observed increased blood ﬂow for negative pressures of up
to -300 mmHg, but no reduction of blood ﬂow. A higher negative
pressure can therefore be considered to be more effective, espe-
cially as a sufﬁcient pressure to obtain an airtight wound must be
applied in our patients. However, the main limiting factor is pain.
A pressure of about −100/−125 mmHg  appeared to constitute a
good compromise. The continuous or pulsed mode was not studied
in this series.
The high cost of NPWT may  constitute a drawback: the NPWT
device costs D 3500 to D 15,000 and each dressing costs about D 50.
However, it has been estimated that the decreased nursing work-
load, the decreased frequency of dressing changes and the more
rapid wound healing would result in shorter hospital stays [23].
A study conducted in Nantes showed that the cost of hospitalisa-
tion in the plastic surgery ward was  signiﬁcantly lower for patients
treated by NPWT (P = 0.02) than for other patients, with a mean cost
saving of D 6000 per patient [24].
In 2010, in view of the ﬁnancial stakes for hospitals, the arrival
of several competitor devices and user expectations in terms of
clinical practice guidelines, the French Haute Autorité de santé
decided to evaluate NPWT. Based on a meta-analysis, the HAS [25]
showed that, in the presence of extensive wound dehiscence or
in an unfavourable site, with or without superinfection, previouslymation of good quality granulation tissue, resulting in decreased
complexity and/or dimensions of the wound, avoid retraction of
the wound edges, accelerate the possibility of secondary closure
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nd facilitate drainage of secretions. Although sufﬁcient evidence
n favour of NPWT is lacking in the literature, the HAS working party
onsidered that, in view of the severity of the diseases concerned
nd the efﬁcacy of NPWT observed in routine clinical practice, a
andomized trial is not necessary at the present time.
. Conclusion
Pharyngocutaneous ﬁstulas constitute a dreaded complication
f head and neck cancer surgery, particularly total laryngectomies
nd pharyngolaryngectomies. Factors predisposing to ﬁstula for-
ation are malnutrition, diabetes and neck radiotherapy, a
requent situation in view of the current tendency in favour of
arynx preservation strategies.
Management of ﬁstulas must be based on a global approach,
tarting with prevention by acting on the main risk factors, and
hen curative management. Although ﬁrst-line treatment consists
f surgical revision for direct closure using muscle ﬂaps if nec-
ssary, NPWT is a valuable alternative, particularly in the setting
f repeated surgery or an unfavourable beneﬁt/risk balance for
urgery.
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